Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical spironolactone vs topical clindamycin for mild to moderate acne vulgaris
IRCT20220720055503N1Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in acne vulgaris comparing Topical spironolactone solution with Topical clindamycin solution (2 arms). Started Jul 2022; status: completed.
02
Drugs
spironolactoneclindamycin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on IRCT20220720055503N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220720055503N1.